Class 2 Medicines Recall: Lucentis 10 mg/ml solution for injection in pre-filled syringe (Novartis Pharmaceuticals UK) batch 21B15IA
Class 2 MHRA medicines recall – Lucentis 10 mg/ml solution for injection in pre-filled syringe (Novartis Pharmaceuticals UK) batch 21B15IA
Drug alert number: EL (21)A/36
MDR Number: MDR 017-12/21
Date issued: 13 December 2021
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
Lucentis 10 mg/ml solution for injection in pre-filled syringe (Novartis Pharmaceuticals UK) batch 21B15IA
Novartis Pharmaceuticals UK are recalling the batch listed below due to a faulty plunger stopper which has led to an increased number of customer complaints relating to the plunger being difficult to press down. The faulty plunger stopper batch has only been used in batch 21B15IA and no other batches of Lucentis are impacted.
Product | Batch Number | Expiry Date | Pack Size | First Distributed | |||
Lucentis 10 mg/ml solution for injection in pre-filled syringe, 5ml, (PLGB 00101/1103 EU/1/06/374/003) | 21B15IA | Jan 2024 | 1 | 07 September 2021 |
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Further information
Full drug alert can be viewed here.
Company contacts for further information
For more information or medical information queries, please contact: 01276 698370, or email medinfo.uk@novartis.com
For stock control queries, please contact: 08457 419442, or email claims.customer_care@novartis.com